Tirzepatide is based on the GIP sequence and contains aminoisobutyric acid (Aib) in positions 2 and 13, a C-terminal amide, and Lys residue at position 20 that is attached to 1,20-eicosanedioic acid via a linker
Experimental studies demonstrated that modulation of NNMT pathways could influence metabolic signaling networks involved in cellular energy utilization and body composition regulation
Systemic symptoms such as fever, chills, or malaise following injection warrant immediate medical evaluation
Tirzepatide Glycine Cyanocobalamin (Vitamin B12) Suggested Dosing Injections should be administered subcutaneously (under the skin) one time weekly
Patients should be informed of the pros and cons of oral versus parenteral therapy, and regardless of the form of treatment, those with pernicious anemia or malabsorption should be reminded of the need for lifelong replacement
contact your healthcare provider if you notice anything unusual